BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 26880796)

  • 21. Comparative aspects of intracellular proteolytic processing of peptide hormone precursors: studies of proopiomelanocortin processing.
    Tanaka S
    Zoolog Sci; 2003 Oct; 20(10):1183-98. PubMed ID: 14569141
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 60 YEARS OF POMC: POMC: an evolutionary perspective.
    Navarro S; Soletto L; Puchol S; Rotllant J; Soengas JL; Cerdá-Reverter JM
    J Mol Endocrinol; 2016 May; 56(4):T113-8. PubMed ID: 26671895
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Proopiomelanocortin-derived peptides.
    Bertagna X
    Endocrinol Metab Clin North Am; 1994 Sep; 23(3):467-85. PubMed ID: 7805649
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multiple sorting systems for secretory granules ensure the regulated secretion of peptide hormones.
    Sun M; Watanabe T; Bochimoto H; Sakai Y; Torii S; Takeuchi T; Hosaka M
    Traffic; 2013 Feb; 14(2):205-18. PubMed ID: 23171199
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Activity-dependent dynamics of coexisting brain-derived neurotrophic factor, pro-opiomelanocortin and alpha-melanophore-stimulating hormone in melanotrope cells of Xenopus laevis.
    Wang LC; Meijer HK; Humbel BM; Jenks BG; Roubos EW
    J Neuroendocrinol; 2004 Jan; 16(1):19-25. PubMed ID: 14962071
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Proteolytic processing of pro-opiomelanocortin occurs in acidifying secretory granules of AtT-20 cells.
    Tanaka S; Yora T; Nakayama K; Inoue K; Kurosumi K
    J Histochem Cytochem; 1997 Mar; 45(3):425-36. PubMed ID: 9071324
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pro-opiomelanocortin processing in the hypothalamus: impact on melanocortin signalling and obesity.
    Pritchard LE; Turnbull AV; White A
    J Endocrinol; 2002 Mar; 172(3):411-21. PubMed ID: 11874690
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of pepstatin A, an inhibitor of the pro-opiomelanocortin (POMC)-converting enzyme, on POMC processing in mouse intermediate pituitary.
    Loh YP
    FEBS Lett; 1988 Sep; 238(1):142-6. PubMed ID: 2844592
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An in vivo characterization of the cleavage site specificity of the insulin cell prohormone processing enzymes.
    Thorne BA; Thomas G
    J Biol Chem; 1990 May; 265(15):8436-43. PubMed ID: 2160459
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Spatiotemporal expression, distribution, and processing of POMC and POMC-derived peptides in murine skin.
    Mazurkiewicz JE; Corliss D; Slominski A
    J Histochem Cytochem; 2000 Jul; 48(7):905-14. PubMed ID: 10858267
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential effects of fasting and leptin on proopiomelanocortin peptides in the arcuate nucleus and in the nucleus of the solitary tract.
    Perello M; Stuart RC; Nillni EA
    Am J Physiol Endocrinol Metab; 2007 May; 292(5):E1348-57. PubMed ID: 17227963
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Secretory pathways and processing of human proopiomelanocortin (POMC) using transformed mouse cultured fibroblasts (L cells) and AtT20 cells by human POMC gene--preembedding immunoelectron microscopic studies.
    Osamura RY; Suemizu Y; Yoshimura S; Hori S; Inada K; Watanabe K; Nakai Y; Imura H
    Peptides; 1991; 12(3):503-7. PubMed ID: 1656400
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The tissue-specific processing of pro-opiomelanocortin.
    Bicknell AB
    J Neuroendocrinol; 2008 Jun; 20(6):692-9. PubMed ID: 18601691
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Loss of hypothalamic Furin affects POMC to proACTH cleavage and feeding behavior in high-fat diet-fed mice.
    Coppola I; Brouwers B; Walker L; Alar C; Meulemans S; White A; Ramos-Molina B; Creemers JWM
    Mol Metab; 2022 Dec; 66():101627. PubMed ID: 36374777
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The amino-terminal sequence of pro-opiomelanocortin directs intracellular targeting to the regulated secretory pathway.
    Tam WW; Andreasson KI; Loh YP
    Eur J Cell Biol; 1993 Dec; 62(2):294-306. PubMed ID: 7925485
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Processing of pro-opiomelanocortin in GH3 cells: inhibition by prohormone convertase 2 (PC2) antisense mRNA.
    Friedman TC; Cool DR; Jayasvasti V; Louie D; Loh YP
    Mol Cell Endocrinol; 1996 Jan; 116(1):89-96. PubMed ID: 8822269
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Production of pro-opiomelanocortin (POMC) by a vaccinia virus transient expression system and in vitro processing of the expressed prohormone by POMC-converting enzyme.
    Andreasson KI; Tam WW; Feurst TO; Moss B; Loh YP
    FEBS Lett; 1989 May; 248(1-2):43-7. PubMed ID: 2542089
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification and possible function of pro-opiomelanocortin-derived peptides in the testis.
    Bardin CW; Shaha C; Mather J; Salomon Y; Margioris AN; Liotta AS; Gerendai I; Chen CL; Krieger DT
    Ann N Y Acad Sci; 1984; 438():346-64. PubMed ID: 6100019
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Post-translational processing of proopiomelanocortin in the pituitary and in the brain.
    Castro MG; Morrison E
    Crit Rev Neurobiol; 1997; 11(1):35-57. PubMed ID: 9093813
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PACS-1 and adaptor protein-1 mediate ACTH trafficking to the regulated secretory pathway.
    Dirk BS; End C; Pawlak EN; Van Nynatten LR; Jacob RA; Heit B; Dikeakos JD
    Biochem Biophys Res Commun; 2018 Dec; 507(1-4):519-525. PubMed ID: 30458990
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.